drugset / Trial / NCT00819572

Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee

NCT00819572 ↗

Phase 1/2 Completed 27 enrolled ESBATech AG
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether an intra-articular injection of DLX105 to the knee joint of patients suffering from severly painful osteoarthritis is safe and reduces pain.

Timeline

Start
2008-12
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject DLX105 Protein / enzyme biologic — Other

Indications